Denosumab for prevention of fractures in men receiving androgen deprivation therapy (ADT) for prostate cancer (PC)

被引:0
|
作者
Saad, F.
Smith, M. R.
Egerdie, B.
Tammela, T. L.
Feldman, R. A.
Heracek, J.
Szwedowski, M.
Ke, C.
Leder, B.
Goessl, C.
机构
[1] Univ Montreal, Ctr Hosp, Montreal, PQ, Canada
[2] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
[3] Urol Associates, Urol Med Res, Kitchener, ON, Canada
[4] Tampere Univ Hosp, Tampere, Finland
[5] Connecticut Clin Res Ctr, Urol Specialists, Middlebury, CT USA
[6] Androgeos, Prague, Czech Republic
[7] Wojewodzkie Ctr Medyczne, Opole, Poland
[8] Amgen Inc, Thousand Oaks, CA 91320 USA
[9] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5056
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Quality of care provided to prostate cancer (PC) patients for prevention and treatment of osteoporosis induced by androgen deprivation therapy (ADT)
    Chahin, Rehab
    Gulamhusein, Husayn
    Breunis, Henriette
    Alibhai, Shabbir M. H.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (11) : 4713 - 4720
  • [22] Impact of resistance exercise on metabolic syndrome (MetS) parameters in men receiving androgen deprivation therapy (ADT) for prostate cancer
    Dorff, T.
    Gross, M.
    Quinn, D. I.
    Pinski, J.
    Schroeder, T.
    Groshen, S.
    Dieli-Conwright, C.
    Kiwata, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [23] Resistance exercise in men receiving androgen deprivation therapy for prostate cancer
    Segal, RJ
    Reid, RD
    Courneya, KS
    Malone, SC
    Parliament, MB
    Scott, CG
    Venner, PM
    Quinney, HA
    Jones, LW
    D'Angelo, MES
    Wells, GA
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (09) : 1653 - 1659
  • [24] Bone health in men receiving androgen deprivation therapy for prostate cancer
    Eastham, James A.
    JOURNAL OF UROLOGY, 2007, 177 (01): : 17 - 24
  • [25] Quality of care provided to prostate cancer (PC) patients for prevention and treatment of osteoporosis induced by androgen deprivation therapy (ADT)
    Rehab Chahin
    Husayn Gulamhusein
    Henriette Breunis
    Shabbir M.H. Alibhai
    Supportive Care in Cancer, 2016, 24 : 4713 - 4720
  • [26] Racial differences in bone mineral density and fractures in men receiving androgen deprivation therapy for prostate cancer
    Morgans, A. K.
    Hancock, M. L.
    Barnette, G.
    Steiner, M. S.
    Morton, R. A.
    Smith, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [27] Racial Differences in Bone Mineral Density and Fractures in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
    Morgans, Alicia K.
    Hancock, Michael L.
    Barnette, K. Gary
    Steiner, Mitchell S.
    Morton, Ronald A.
    Smith, Matthew R.
    JOURNAL OF UROLOGY, 2012, 187 (03): : 889 - 893
  • [28] Androgen deprivation therapy (ADT) for node postive prostate cancer
    Wong, Y.
    Freedland, S.
    Hudes, G.
    Mitra, N.
    Montagnet, C.
    Armstrong, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] MUSCULOSKELETAL HEALTH IN ANDROGEN DEPRIVATION THERAPY (ADT) FOR PROSTATE CANCER
    Zigoura, E.
    Veronese, N.
    Floris, A.
    Schiavone, C.
    Campodonico, F.
    Ennas, M.
    Pilotto, A.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S282 - S282
  • [30] Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer
    Shahinian, VB
    Kuo, YF
    Freeman, JL
    Goodwin, JS
    ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (04) : 465 - 471